ECO Animal Health Group plc is a United Kingdom-based company engaged in the development, registration, and marketing of pharmaceutical products for global animal health markets. The Company’s segment includes the United Kingdom, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World. The Company researches, develops and commercializes products for livestock. The Company’s patented drug, Aivlosin, is a macrolide antibiotic for treatment of respiratory and enteric diseases in pigs and poultry. The Company’s generic drugs include Ecomectin, Ecoheart, Ecotraz and Ecomintic, which are endectocides and other antiparasitic drugs. Its generic drugs are developed for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs. The Company’s Chlortetracycline and Oxytetracycline are developed for the treatment of bacterial infections in pigs, poultry, and cattle.